| Bioactivity | Fmoc-Gly3-VC-PAB-MMAE is a Drug-Linker Conjugates for ADC. Fmoc-Gly3-VC-PAB-MMAE consists of Monomethyl auristatin E (HY-15162) and a linker[1]. |
| Name | Fmoc-Gly3-VC-PAB-MMAE |
| Formula | C79H113N13O17 |
| Molar Mass | 1516.82 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337. |
Fmoc-Gly3-VC-PAB-MMAE
CAS: F: C79H113N13O17 W: 1516.82
Fmoc-Gly3-VC-PAB-MMAE is a Drug-Linker Conjugates for ADC. Fmoc-Gly3-VC-PAB-MMAE consists of Monomethyl auristatin E (HY
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.